Toll Free Assessment
866-720-3784
Drug Rehab Treatment Centers

Pennsylvania/category/alaska/maryland/pennsylvania Treatment Centers

Buprenorphine used in drug treatment in Pennsylvania/category/alaska/maryland/pennsylvania

There are a total of 0 drug treatment centers listed under the category Buprenorphine used in drug treatment in pennsylvania/category/alaska/maryland/pennsylvania. If you have a facility that is part of the Buprenorphine used in drug treatment category you can contact us to share it on our website. Additional information about these listings in Pennsylvania/category/alaska/maryland/pennsylvania is available by phoning our toll free rehab helpline at 866-720-3784.

Rehabilitation Categories

We have carefully sorted the 0 drug rehab centers in pennsylvania/category/alaska/maryland/pennsylvania. Filter your search for a treatment program or facility with specific categories. You may also find a resource using our addiction treatment search. For additional information on pennsylvania/category/alaska/maryland/pennsylvania drug rehab please phone our toll free helpline.

Drug Facts

  • More than 50% of abused medications are obtained from a friend or family member.
  • 30% of emergency room admissions from prescription abuse involve opiate-based substances.
  • 7.6% of teens use the prescription drug Aderall.
  • 2.3% of eighth graders, 5.2% of tenth graders and 6.5% of twelfth graders had tried Ecstasy at least once.
  • From 1961-1980 the Anti-Depressant boom hit the market in the United States.
  • Illicit drug use is estimated to cost $193 billion a year with $11 billion just in healthcare costs alone.
  • Barbituric acid was first created in 1864 by a German scientist named Adolf von Baeyer. It was a combination of urea from animals and malonic acid from apples.
  • Most heroin is injected, creating additional risks for the user, who faces the danger of AIDS or other infection on top of the pain of addiction.
  • Heroin was first manufactured in 1898 by the Bayer pharmaceutical company of Germany and marketed as a treatment for tuberculosis as well as a remedy for morphine addiction.
  • Most people use drugs for the first time when they are teenagers. There were just over 2.8 million new users (initiates) of illicit drugs in 2012, or about 7,898 new users per day. Half (52 per-cent) were under 18.
  • The number of people receiving treatment for addiction to painkillers and sedatives has doubled since 2002.
  • The effects of synthetic drug use can include: anxiety, aggressive behavior, paranoia, seizures, loss of consciousness, nausea, vomiting and even coma or death.
  • Illicit drug use in America has been increasing. In 2012, an estimated 23.9 million Americans aged 12 or olderor 9.2 percent of the populationhad used an illicit drug or abused a psychotherapeutic medication (such as a pain reliever, stimulant, or tranquilizer) in the past month. This is up from 8.3 percent in 2002. The increase mostly reflects a recent rise in the use of marijuana, the most commonly used illicit drug.
  • Over 5% of 12th graders have used cocaine and over 2% have used crack.
  • Teens who have open communication with their parents are half as likely to try drugs, yet only a quarter of adolescents state that they have had conversations with their parents regarding drugs.
  • Victims of predatory drugs often do not realize taking the drug or remember the sexual assault taking place.
  • More than half of new illicit drug users begin with marijuana. Next most common are prescription pain relievers, followed by inhalants (which is most common among younger teens).
  • Approximately 28% of teens know at least one person who has used Ecstasy, with 17% knowing more than one person who has tried it.
  • Drug addiction and abuse can be linked to at least of all major crimes committed in the United States.
  • 19.3% of students ages 12-17 who receive average grades of 'D' or lower used marijuana in the past month and 6.9% of students with grades of 'C' or above used marijuana in the past month.

Free non-judgmental advice at

866-720-3784